ONCOLOGIC Trademark

Trademark Overview


On Tuesday, December 3, 2002, a trademark application was filed for ONCOLOGIC with the United States Patent and Trademark Office. The USPTO has given the ONCOLOGIC trademark a serial number of 76474942. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, November 19, 2003. This trademark is owned by Curascript Pharmacy, Inc.. The ONCOLOGIC trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Health care services, namely to provide intense care management for patients receiving medications for oncology conditions

General Information


Serial Number76474942
Word MarkONCOLOGIC
Filing DateTuesday, December 3, 2002
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, November 19, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHealth care services, namely to provide intense care management for patients receiving medications for oncology conditions
Pseudo MarkONCOLOGY CONDITIONS LOGIC

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 30, 2002
Primary Code044
First Use Anywhere DateTuesday, May 1, 2001
First Use In Commerce DateTuesday, May 1, 2001

Trademark Owner History


Party NameCurascript Pharmacy, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOrlando, FL 32822

Trademark Events


Event DateEvent Description
Thursday, October 7, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 19, 2003ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, March 31, 2003NON-FINAL ACTION MAILED
Monday, March 17, 2003ASSIGNED TO EXAMINER